Tag Archives: Ophthalmology

Comparison of age-related macular degeneration treatments trials: Lucentis-Avastin trial

January 18th, 2012 - 12:22 pm

Sophie J. Bakri, M.D., with the Department of Ophthalmology at Mayo Clinic in Rochester, Minn., and study principal investigator at Mayo Clinic, discusses first-year results from the National Eye Institute–funded study of neovascular age-related macular degeneration (AMD). Findings indicate that bevacizumab … Continue reading →

By Miriam Wuensch | Posted in Ophthalmology | Tagged , , , , , , , | Leave a comment

E2-2 protein and Fuchs corneal dystrophy

January 25th, 2011 - 11:14 am

Keith H. Baratz, M.D. of the Department of Ophthalmology discusses a genomewide association study that indicates a genetic variation in TCF4 contributes to the development of Fuchs corneal dystrophy (FCD).   ABSTRACT Background Fuchs corneal dystrophy is a leading cause of corneal … Continue reading →

By Miriam Wuensch | Posted in Ophthalmology | Tagged , , , , | Comments (2)